Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen.
about
New insights into MicroRNAs involves in drug resistance in diffuse large B cell lymphomaAntibody-Array-Based Proteomic Screening of Serum Markers in Systemic Lupus Erythematosus: A Discovery StudyTumor necrosis factor receptor 2 may promote the proliferation and drug resistance of Kapras299 and L428 lymphoma cells via the AKT and WNT/β-catenin signaling pathways.
P2860
Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Serum level of soluble tumor n ...... eated with the R-CHOP regimen.
@en
Serum level of soluble tumor n ...... eated with the R-CHOP regimen.
@nl
type
label
Serum level of soluble tumor n ...... eated with the R-CHOP regimen.
@en
Serum level of soluble tumor n ...... eated with the R-CHOP regimen.
@nl
prefLabel
Serum level of soluble tumor n ...... eated with the R-CHOP regimen.
@en
Serum level of soluble tumor n ...... eated with the R-CHOP regimen.
@nl
P2093
P2860
P356
P1476
Serum level of soluble tumor n ...... eated with the R-CHOP regimen.
@en
P2093
Hisashi Tsurumi
Hisataka Moriwaki
Ichiro Yasuda
Masahito Shimizu
Masao Takemura
Michio Sawada
Mitsuru Seishima
Nobuhiko Nakamura
Nobuhiro Kanemura
P2860
P304
P356
10.1111/EJH.12139
P577
2013-07-07T00:00:00Z